OrbiMed Closes $600M Fund

Investment firm OrbiMed held a final close of its new fund, Royalty Opportunities S.àr.l., which will focus on acquiring healthcare royalty streams and providing structured debt capital to healthcare companies. The fund, based in Luxembourg, closed with $600 million in commitments.

DealsNorth AmericaUSBriefs